| 
                  
                 | 
               
              
                | Ness Technologies' 
                  Raviv Zoeller: Managing others' R&D out of India | 
               
             
            In 
              a lean period for business news, they would have made headlines. 
              The past few months, however, as anyone who reads the papers, white 
              and pink, will aver, have been anything but lean. And so it is, 
              that three significant developments related to the stockmarket have 
              almost gone completely unnoticed. The first is the government's 
              refusal to institute a market stabilisation fund to artificially 
              prop up the market in case of a bear run. The second is its decision 
              to allow insurance companies, both state-owned and private sector, 
              to invest in large and high-quality initial public offerings (IPOs). 
              And the third is its proposal to amend Section 20 of the Indian 
              Trusts Act of 1882, to allow trusts to park short-term funds in 
              securities of their choice instead of those earmarked by the government. 
               
             All three point to a common end: the Indian 
              capital market has come of age. The government would seem to have 
              decided that it is something that can fend for itself and be opened 
              up to new players such as insurance companies that typically have 
              a very long-term perspective of risk and return. 
            
             
              In terms of structural parameters such as operational and systemic 
              risk management, settlement systems, disclosures norms, and accounting 
              standards, the Indian securities market is at par with the best 
              in the world.  
             Take the case of settlement of stock transactions. 
              In the UK, weekly settlements are still the norm; the NYSE (New 
              York Stock Exchange) follows a t+3 system, which means all settlement 
              must be made within three days of the transaction; but the Indian 
              stock market has already moved to a t+2 norm (it did so in April 
              2003). "Even the transparency exhibited in the IPO book-building 
              process in India is not witnessed in developed markets," contends 
              Ajay Bagga, CEO, Kotak Mahindra Asset Management Company.  
             Yet, the Indian stockmarket continues to remain 
              shallow, vacillating between scams and market misconduct. For instance, 
              since the second half of the 1990s when the markets became far more 
              transparent and accessible to millions of middle-class Indians, 
              they have been ravaged by one scam after another, CRB Mutual Fund 
              in 1997, the Harshad Mehta scam of 1992 and, again, 1998, UTI in 
              1998 and, again, 2001, and the Ketan Parekh scam of 2001. And while 
              the past few years have not witnessed any scams, the Indian stockmarket 
              is still woefully short of depth and width. In part, this has to 
              do with the limited free float of shares of many companies. "Since 
              promoters routinely hold 40 to 50 per cent of the stocks in their 
              company, there is little free float available making the "impact 
              cost'' very high for bulk purchases,'' says Bagga. What he means 
              is that if you want to buy lots of shares of a single company, you 
              have to pay a very high amount. 
             And, in part, this has to do with the limited 
              participation of retail investors and domestic financial institutions. 
              Today, while foreign institutional investors (FIIs) have invested 
              around $60 billion (Rs 2,70,000 crore) in the stock market, and 
              high net worth individuals around $30 billion (Rs 1,35,000 crore), 
              domestic financial institutions and the retail investor have invested 
              as little as $15 to $17 billion (Rs 67,500 crore to Rs 76,500 crore). 
              In the US, retail investors control nearly 50 per cent of the total 
              stocks in play through pension funds or mutual funds. In numerical 
              terms, 39 per cent of the American population is an active participant 
              in the $14 trillion (Rs 6,30,00,000 crore) American stock market; 
              in India, the corresponding figures are 1.5 per cent and $350 billion 
              (Rs 15,75,000 crore). Which is where the move to allow pension funds 
              and insurance companies (both long-term players) to invest in the 
              stockmarket could help (analysts mention the specifics of higher 
              liquidity, more stability, and greater depth). After all, it was 
              President Reagan's decision to allow pension funds to invest in 
              stocks in 1981 that set off a 15-year bull run in the US. 
             -Ashish Gupta 
             
              ON THE ROAD DEPARTMENT 
              Bloodline 
              India's first cord blood stem-cell bank, Lifecell, 
              opens shop in Chennai. Big Deal? You bet! 
            
               
                | 
                  
                 | 
               
               
                | CRYO-CELL's 
                  Abhaya Kumar: Futureproofing us | 
               
             
            The 
              future of genetic medicine can be found at Keelakotaiyur in Tamil 
              Nadu where India's first cord blood stem-cell bank Lifecell will 
              soon be functional. Stem-cells, for the uninitiated, are super-cells 
              that are versatile enough to perform a variety of functions and 
              research is on to condition them to grow into entire organs or parts 
              of them (think cardiac tissue, lung and liver cells and the like). 
              The new, researchers hope, can replace the old and the worn within 
              the human body, increasing longevity and serving as a miracle cure 
              for degenerative disorders.  
             This branch of medicine is called regenerative 
              medicine and it is no longer in the realm of science fiction. Cord-blood, 
              collected from the umbilical cord, is a rich source of stem-cells 
              and is already considered a better alternative than anything else 
              for use in transplants that people suffering from leukemia and other 
              immune disorders undergo. The cord blood of a newborn can be used 
              in case it contracts an immunological disease later in life, or 
              in case any of its siblings does. And, if all goes well, as already 
              hinted, it can one day help a donor in his or her dotage combat 
              Parkinson's or multiple sclerosis (yup, stem-cells can treat these 
              degenerative diseases too).  
             All this doesn't come cheap. Asia cryo-cell, 
              promoted by S. Abhaya Kumar, one of the men behind Shasun Chemicals 
              & Drugs, a Rs 273-crore bulk drugs manufacturer, and which has 
              a licensing arrangement with the us-based cryo-cell International 
              Inc., the world's largest cord blood stem cell banking firm, plans 
              to charge customers a one-time fee of Rs 59,000 or an equivalent 
              yearly payment, to store the stem-cells for 21 years.  
             At the end of this period (the newborn is now 
              old enough to take a decision), the donor can decide whether he 
              or she wants to continue with the storage. "We are still the 
              cheapest in Asia," says Abhaya Kumar, the Vice Chairman and 
              CEO of the company. Asia cryo-cell has invested Rs 12 crore in the 
              facility and hopes to break even by end-2007, by which time it will 
              have around 10,000 customers; and this point of inflection factors 
              in storing the cells for 100 years elsewhere, should the company 
              go bust, and a contingency storage plan with the Manila Institute 
              of Life Sciences.  
             Abhaya Kumar's comment on cost isn't out of 
              place-it costs anything between $15,000-16,000 (Rs 6.75 lakh-Rs 
              7.2 lakh) to store cord blood stem-cells for 21 years anywhere else 
              in the world-but fact is, 75 of the 100 such banks currently present 
              in the world are public ones that do not charge donors anything 
              for collection and storage (donors who need stem cells later will, 
              alas, still have to pay for them and are usually not guaranteed 
              the return of the very cells they have donated).  
             Asia cryo-cell itself, discloses Abhaya Kumar, 
              plans to set up a public bank and charge buyers in line with the 
              market rates that could be anything upwards of Rs 3 lakh for a match. 
              The donors though, pay nothing. And cryo-cell plans to use some 
              samples in the research into diabetes it plans to carry out in association 
              with the Manila Institute of Life Sciences. 
             As for the future of medicine, it may not be 
              as far away as it seems. To date, there have been some 15 transplants 
              in India involving the use of stem-cells. 
            -Nitya Varadarajan 
             
             Not 
              Yet, But... 
              Banks tread thin ice in a desire to leverage 
              the IPO-financing boom to their benefit.  
            
               
                |  
                  
                 | 
               
               
                | Paper money: 
                  It's boom time for IPO financiers as many companies go public | 
               
             
            The revival of the 
            initial public offering (IPO) market-thus far, this year, 18 companies 
            have raised Rs 29,400 crore through IPOs-has meant a boom in IPO-financing 
            by banks. That's a good sign, and to ensure that nothing goes wrong, 
            the Reserve Bank of India has put down stringent guidelines for IPO-financing. 
            For instance, the maximum permissible loan is Rs 10 lakh and that 
            too, only if the borrower can put down an equal margin (that means 
            the borrower has to put down Rs 5 lakh). Yet, some banks, it would 
            seem are violating this, and because this practice is largely being 
            carried out by 'collecting bankers' the phenomenon hasn't become very 
            visible.  
            Here's how this works. Assume that you approach 
              a 'collecting bank' (bank collecting IPO forms and the money paid) 
              for a loan of Rs 5 lakh to invest Rs 10 lakh in the same IPO. The 
              bank takes Rs 5 lakh from you and also gives you a loan of Rs 5 
              lakh. As the issuing company is authorised to get the money only 
              after the issue is over, the entire money (Rs 10 lakh) is kept with 
              the bank itself (in another account). So for the bank, it is just 
              a book entry (although you, as a borrower, will still have to pay 
              interest). As most issues are oversubscribed, the banks don't lose 
              anything. For instance, if the issue is oversubscribed twice over, 
              and you receive only shares worth Rs 5 lakh (against your application 
              for Rs 10 lakh worth), the bank will release your money to the issuer 
              and reverse your loan by another book entry. In that sense, the 
              banks are making money for nothing. 
             Herein lies the catch: because this is money 
              for nothing or "free money", bankers have been tempted 
              to become more aggressive and finance more of the application amount. 
              This is against regulations (according to RBI), and it isn't. That's 
              because, these loans are being masked as normal loans. For instance, 
              if you are going to apply for Rs 10-lakh worth of shares in an IPO, 
              the bank can give you a IPO-loan of Rs 5 lakh, and a personal loan 
              of Rs 4 lakh. That way, your contribution will be just Rs 1 lakh 
              (or 10 per cent). Here again, the banks will be totally safe if 
              the issue is oversubscribed by more than 10 times. After all, that 
              would mean that you just get shares for Rs 1 lakh (the amount you 
              have actually paid up). Still, it would be foolish to expect that 
              the current fever of oversubscriptions (downright obscene in some 
              cases) will continue. And if the market crashes in the middle of 
              things, the bank may have to take a major hit. Is this within RBI's 
              control? Indeed, it is; the central bank can simply restrict banks 
              from lending for IPOs for which they are also 'collecting banks'. 
            -Narendra Nathan 
             
             IDEA  
              Retail Brotherhood 
            
               
                  | 
               
             
            Decades ago, when dairy 
              farmers in India realised that market middlemen weren't helping 
              them get the best prices for their products, they launched a cooperative 
              federation, which today is a giant called Amul. Circa 2005, it's 
              now the turn of small food retailers to set up a self-help group 
              of their own-but with the know-how from a Dutch cooperative called 
              spar. Spearheading the movement in India is Radhakrishna Foodland 
              (a retail logistics company, and part of the Radhakrishna Group), 
              which recently obtained a licence from spar to launch a food retailer 
              cooperative in the country. As in the 34 other countries where spar 
              operates, the idea in India is to bring together small mom-n-pop 
              retailers (only food in India's case) and help them with retail 
              technology, including everything from staffing to training and sourcing 
              to marketing. Says Raju Shete, Chairman & Managing Director, 
              Radhakrishna Foodland: "We believe that the entry of the spar 
              brand into India will usher in a new cooperative model in food retailing, 
              solely aimed at protecting the interest of the independent retailer 
              members." The first spar store will open at Juhu in Mumbai 
              in December this year and will showcase the benefits of retail the 
              spar way. Given that there are thousands of small and independent 
              food retailers in the country, Radhakrishna may just cook up a retail 
              revolution.  
            -Roshni Jayakar 
             
             NEWSMAKER 
              Phase III Diva 
            
             Who is this lady?  
             Deepanwita Chattopadhyay, CEO, ICICI Knowledge 
              Park. 
             Why is she here?  
            She is CEO of India's best-known biotech and 
              pharma park (in Hyderabad), which is probably the only professionally 
              managed research park in India.  
             And...? 
            Well, the park is into its third phase now (bookings 
              complete). The first two phases, that cost Rs 39 crore, saw it build 
              a total laboratory space of 58,000 sq. ft. that is now occupied 
              by 14 companies, Indian and multinational. The third phase will 
              see the construction of an additional 22,000 sq. ft. of lab-space 
              at a cost of Rs 7 crore.   
            -E. Kumar Sharma 
             
             Brussels, 
              Madrid, New Delhi, Mumbai 
              Louis Vuitton's Chairman and CEO insists they 
              are in the same league.  
            
               
                |  
                  
                 | 
               
               
                | Louis Vuitton's 
                  Yves Carcelle: He can smell the rich a thousand miles away | 
               
             
            It 
              warms the insides of even a hard-nosed journalist like yours truly 
              when Mumbai and New Delhi are equated with Brussels, the seat of 
              the European Union, and Madrid, Spain's most happening city. So, 
              while Yves Carcelle, Chairman and CEO of the Paris-based fashion 
              house Louis Vuitton, part of luxury goods major LVMH, is unwilling 
              to say how much business the brand's first outlet in India, in New 
              Delhi, does, or how much the second, in Mumbai and it has just opened 
              for business, hopes to do, he sweetens his refusal by adding that 
              "Mumbai or Delhi would be in the league of Madrid or Brussels." 
              He thinks for a moment and adds, "Shanghai is in an altogether 
              different league of Tier-I cities." One would have guessed 
              as much, but this isn't about Shanghai (a Tier-I city, according 
              to Louis Vuitton means independent stores in the city do a business 
              of around 20 million euros, Rs 119- crore, each); it is about Delhi 
              and Mumbai; ergo, the happy feeling described in the opening sentence 
              of this composition.  
             Then, the realisation sinks in that when Monsieur 
              Carcelle says Mumbai and Delhi, he is referring to the Mumbai of 
              the Taj Mahal Hotel, Apollo Bunder and the Delhi of the Oberoi Hotel, 
              Zakir Hussain Marg where the Louis Vuitton stores are based. "We 
              usually start in new markets in protected environments such as these," 
              says Carcelle. "We don't want to risk having Kentucky Fried 
              Chicken (KFC) next door." His reference is generic, so this 
              writer doesn't press the point about KFC having all but exited India 
              (the last store is in Bangalore, and was still serving chickens 
              when this magazine went to Press, although an alert on the website 
              of the Indian arm of PETA, People For Ethical Treatment of Animals, 
              urges viewers to 'ask KFC to get the cluck out of India') and decides 
              to eye the merchandise.  
             The 2,500-sq. ft. store at the Taj stocks a 
              range of the firm's leather products, shoes, and accessories with 
              prices ranging from Rs 5,000 for a key chain to Rs 7,00,000 for 
              a suitcase that obviously goes with this. "When an economy 
              sees the rate of growth India is seeing, it means several things 
              are happening," offers Carcelle helpfully, "The most important 
              is that there is a growing breed of entrepreneurs, corporate executives, 
              and in India's case, a mass of non resident Indians returning to 
              participate in the growth here; Bangalore is on the world map; 10 
              years ago, Indians studying in the us stayed on but today they are 
              coming back; all this means mindsets are changing and as pioneers 
              in the fashion business, we see ourselves as market creators and 
              this is exactly what we are here to do."  
             In effect, that would mean that the market 
              for luxury goods in India is no longer restricted to the people 
              who shop abroad (they will probably still do and you can't catch 
              them dead in a Louis Vuitton store in India; one in Paris is more 
              like it) but has moved on to the next lower level.  
             The tipping point, suggests Carcelle, may have 
              well been reached. "Some of our closest rivals are eyeing the 
              market," he says. "The minute we enter a market, they 
              start assessing it."  
            -Priya Srinivasan 
           |